FDA Inspection 1178212 — OMNILIFE USA
The FDA completed an inspection of OMNILIFE USA on Sep 6, 2022 in Dallas, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Food/Cosmetics.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Sep 6, 2022
- Fiscal Year
- 2022
- Product Type
- Food/Cosmetics
- Project Area
- Foodborne Biological Hazards
- Location
- Dallas, TX (United States)
Additional details
FSVP
Citations
| ID | CFR | Description |
|---|---|---|
| 18388 | 21 CFR 1.511(c)(2)(i) | No CGMPs - approval procedures |